Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Bk virus infection? 103 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Bk virus infection have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.1% of all adverse event reports for DOXORUBICIN.

103
Reports of Bk virus infection with DOXORUBICIN
0.1%
of all DOXORUBICIN reports
12
Deaths
37
Hospitalizations

How Dangerous Is Bk virus infection From DOXORUBICIN?

Of the 103 reports, 12 (11.7%) resulted in death, 37 (35.9%) required hospitalization, and 13 (12.6%) were considered life-threatening.

Is Bk virus infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 103 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Bk virus infection?

TACROLIMUS (1,207) MYCOPHENOLATE MOFETIL (1,058) CYCLOSPORINE (817) CYCLOPHOSPHAMIDE (632) PREDNISONE (459) FLUDARABINE (456) PREDNISOLONE (423) METHYLPREDNISOLONE (395) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (356) RITUXIMAB (342)

Which DOXORUBICIN Alternatives Have Lower Bk virus infection Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Bk virus infection Reports All Drugs Causing Bk virus infection DOXORUBICIN Demographics